Diana Mandelker Selected Research

DNA (Deoxyribonucleic Acid)

4/2024	Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings.
3/2024	Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies.
10/2023	Genomic ancestry in kidney cancer: Correlations with clinical and molecular features.
1/2023	Detection of Biallelic Loss of DNA Repair Genes in Formalin-Fixed, Paraffin-Embedded Tumor Samples Using a Novel Tumor-Only Sequencing Panel.
11/2022	Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of "Second Hit" in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma.
1/2022	Morphologic and Genomic Characteristics of Breast Cancers Occurring in Individuals with Lynch Syndrome.
11/2021	Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni Syndrome.
1/2021	Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.
1/2021	Characterization and Clinical Outcomes of DNA Mismatch Repair-deficient Small Bowel Adenocarcinoma.
10/2020	Cancer Susceptibility Mutations in Patients With Urothelial Malignancies.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diana Mandelker Research Topics

Disease

44	Neoplasms (Cancer) 03/2024 - 10/2006
4	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2019
3	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 03/2010
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 04/2023 - 07/2017
2	Carcinogenesis 11/2022 - 10/2009
2	Adenocarcinoma 01/2022 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2020
2	Mesothelioma 01/2020 - 11/2019
2	Disease Progression 01/2019 - 01/2018
1	Hematologic Diseases (Blood Diseases) 03/2024
1	Lobular Carcinoma 11/2023
1	Turcot syndrome 10/2023
1	Microsatellite Instability 10/2023
1	Neuroendocrine Carcinoma 04/2023
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Hemorrhage 11/2021
1	Abdominal Pain (Pain, Abdominal) 11/2021
1	Retinal Telangiectasis 03/2021
1	Retinoblastoma (Glioblastoma, Retinal) 03/2021
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 01/2020
1	Malignant Mesothelioma 01/2020
1	Hereditary leiomyomatosis and renal cell cancer 01/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2020
1	Histiocytosis 12/2019
1	Uveal melanoma 11/2019
1	Nevus (Nevi) 11/2019
1	Astrocytoma (Pilocytic Astrocytoma) 01/2019
1	Glioma (Gliomas) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2018
1	Pheochromocytoma 01/2018
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018
1	Paraganglioma (Paragangliomas) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 07/2017
1	Inborn Urea Cycle Disorders 02/2015
1	Ornithine Carbamoyltransferase Deficiency Disease 02/2015
1	Inflammation (Inflammations) 03/2010
1	Heart Diseases (Heart Disease) 03/2010

Drug/Important Bio-Agent (IBA)

15	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
4	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2018
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 01/2019
3	PlatinumIBA 11/2022 - 01/2019
3	NucleotidesIBA 01/2022 - 07/2017
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 10/2018
3	Protein Isoforms (Isoforms)IBA 03/2010 - 12/2007
2	Cell-Free Nucleic AcidsIBA 03/2024 - 03/2021
2	Calcibiotic Root Canal SealerIBA 01/2022 - 11/2021
2	Fumarate Hydratase (Fumarase)IBA 01/2020 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2019 - 01/2019
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2009 - 12/2007
1	Heme (Haem)IBA 03/2024
1	Cadherins (E-Cadherin)IBA 11/2023
1	olaparibIBA 04/2023
1	ParaffinIBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2023
1	H 77IBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Small Interfering RNA (siRNA)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	N 30IBA 01/2022
1	Circulating Tumor DNAIBA 03/2021
1	Epithelial Cell Adhesion MoleculeIBA 01/2021
1	Topoisomerase II InhibitorsIBA 11/2020
1	1-methyl-1-piperidinomethane sulfonateIBA 01/2020
1	Prostaglandins AIBA 01/2020
1	RibonucleoproteinsIBA 01/2020
1	MutS ProteinsIBA 01/2020
1	CrizotinibIBA 12/2019
1	tyrosine receptor (receptor, tyrosine)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 12/2019
1	selpercatinibIBA 12/2019
1	Checkpoint Kinase 2IBA 06/2019
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Adenosine Monophosphate (AMP)IBA 11/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018
1	CitrullineIBA 02/2015
1	Carbamyl Phosphate (Carbamoyl Phosphate)IBA 02/2015
1	OrnithineIBA 02/2015
1	EnzymesIBA 01/2010
1	IsoenzymesIBA 01/2010

Therapy/Procedure

15	Therapeutics 04/2023 - 01/2010
3	Immunotherapy 01/2022 - 01/2019
2	Precision Medicine 01/2022 - 07/2017
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Treatment Delay 03/2021
1	Gastrectomy 11/2020
1	Castration 07/2017